{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:17:11Z","timestamp":1794575831703,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","progcardvascdis.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pcad.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T14:47:15Z","timestamp":1473864435000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140\/90mmHg"],"prefix":"10.1016","volume":"59","author":[{"given":"Julian E.","family":"Mariampillai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Anders","family":"Esk\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondre","family":"Heimark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre E.","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Narkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2016.09.002_bb0005","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden Of Disease Study 2013","volume":"386","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0010","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0015","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.09.002_bb0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2016.09.002_bb0025","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.09.002_bb0030","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT study group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0035","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.09.002_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Effects of blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0045","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil\u2013Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2016.09.002_bb0050","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2016.09.002_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1747-4949.2010.00573.x","article-title":"The Secondary Prevention of Small Subcortical Strokes (SPS3) study","volume":"6","author":"Benavente","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.pcad.2016.09.002_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/HYPERTENSIONAHA.107.090290","article-title":"Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR\u2013Trandolapril Study","volume":"50","author":"Mancia","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2016.09.002_bb0075","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(04)16456-8","article-title":"Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial","volume":"363","author":"Weber","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0080","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/eurheartj\/ehv633","article-title":"Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial","volume":"37","author":"Mancia","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2016.09.002_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/08037051.2015.1106750","article-title":"No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: the VALUE trial","volume":"25","author":"Kjeldsen","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.pcad.2016.09.002_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/08037051.2015.1127528","article-title":"Importance of sustained and \u201ctight\u201d blood pressure control in patients with high cardiovascular risk","volume":"25","author":"Meredith","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.pcad.2016.09.002_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/HYPERTENSIONAHA.114.04310","article-title":"Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease","volume":"65","author":"Verdecchia","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2016.09.002_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00004872-200018050-00017","article-title":"Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study","volume":"18","author":"Kjeldsen","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2016.09.002_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.mbp.0000200481.64787.c0","article-title":"Automated blood pressure measurement in routine clinical practice","volume":"11","author":"Myers","year":"2006","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.pcad.2016.09.002_bb0110","article-title":"Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients","volume":"1-7","author":"Filipovsky","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.pcad.2016.09.002_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/08037051.2015.1130775","article-title":"The SPRINT study: outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140mmHg rather than below 120mmHg","volume":"25","author":"Kjeldsen","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.pcad.2016.09.002_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/HYPERTENSIONAHA.115.06725","article-title":"Successes of SPRINT, but still some hurdles to cross","volume":"67","author":"Touyz","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2016.09.002_bb0125","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve: pro side of the argument","author":"Mancia","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2016.09.002_bb0130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2016.09.002_bb0135","doi-asserted-by":"crossref","first-page":"i717","DOI":"10.1136\/bmj.i717","article-title":"Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses","volume":"352","author":"Brunstrom","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2016.09.002_bb0140","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062016301049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062016301049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T09:51:43Z","timestamp":1568368303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062016301049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0033062016301049"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2016.09.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140\/90mmHg","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}